---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-044363"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2024-10-28T23:59:59+00:00"
generated_at: "2026-05-30T09:38:25.893443+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Acasti Pharma changes name to Grace Therapeutics; Nasdaq ticker becomes GRCE

## Summary
- Name changed from Acasti Pharma Inc. to Grace Therapeutics, Inc., effective Oct 28, 2024.
- Nasdaq ticker symbol changed from ACST to GRCE on October 28, 2024.
- CUSIP number unchanged at 00439U104; no effect on shareholder rights.
- Bylaws amended only to reflect new corporate name; no other changes made.

## SEC filing metadata
- accession: 0001140361-24-044363
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2024-10-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000114036124044363/0001140361-24-044363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000114036124044363/ef20037633_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-044363
- JSON: https://secwatch.observer/filing/0001140361-24-044363.json
- Plain text: https://secwatch.observer/filing/0001140361-24-044363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.